Literature DB >> 20698046

Decreased IgA+ plasma cells and IgA expression in acute liver necrosis mice.

Jin-Long Fu1, Zhao-Han Wang, Guo-Zhen Li, Yu-Rong Wang, Pei Liu.   

Abstract

AIM: To investigate the number of intestinal immunoglobulin A (IgA+) plasma cells and expression of intestinal IgA in mice with acute liver necrosis.
METHODS: A model of acute liver necrosis was established by intraperitoneal injection of galactosamine (GalN) and lipopolysaccharide (LPS). Sixty mice were randomly divided into one of 4 equal groups: normal control, acute liver necrosis, LPS, or GalN. Hematoxylin and eosin staining, immunohistochemistry, and an enzyme-linked immunosorbent assay were employed to assess liver and intestinal injury, count intestinal IgA+ plasma cells, and measure the expression level of IgA and interferon gamma (IFN-gamma) in the small intestinal mucosa of mice.
RESULTS: Injured intestinal mucosa was observed in the acute liver necrosis group but not in the normal, LPS or GalN groups. Compared with the normal group, intestinal IgA+ plasma cells were slightly decreased in the LPS and GalN groups [429 +/- 20 per high power field (HPF), 406 +/- 18/HPF, respectively], whereas they were markedly decreased in the acute liver necrosis group (282 +/- 17/HPF vs 495 +/- 26/HPF in normal group, P < 0.05). The expression of intestinal IgA was also slightly decreased in LPS and GalN groups, but was markedly reduced in the acute liver necrosis group as determined by enzyme-linked immunosorbent assay (P < 0.05). In contrast, the level of IFN-gamma was slightly increased in LPS, GalN and acute liver necrosis groups, but with no statistical significance (P > 0.05).
CONCLUSION: Intestinal IgA+ plasma cells and IgA expression levels indicating that mucosal immune barrier dysfunction, does exist in acute liver necrosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20698046      PMCID: PMC2921095          DOI: 10.3748/wjg.v16.i30.3827

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

Review 1.  Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID).

Authors:  L Hammarström; I Vorechovsky; D Webster
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

2.  Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM.

Authors:  Benoit Pasquier; Pierre Launay; Yutaka Kanamaru; Ivan C Moura; Séverine Pfirsch; Claude Ruffié; Dominique Hénin; Marc Benhamou; Marina Pretolani; Ulrich Blank; Renato C Monteiro
Journal:  Immunity       Date:  2005-01       Impact factor: 31.745

3.  Tumor necrosis factor-alpha induces apoptosis of enterocytes in mice with fulminant hepatic failure.

Authors:  Hong-Li Song; Sa Lu; Pei Liu
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

4.  Duodenal bulb plasma cells in duodenitis and duodenal ulceration.

Authors:  B B Scott; A Goodall; P Stephenson; D Jenkins
Journal:  Gut       Date:  1985-10       Impact factor: 23.059

Review 5.  Physiology of IgA and IgA deficiency.

Authors:  C Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

Review 6.  Cytokine mediated effects in mucosal immunity.

Authors:  D R Kramer; R M Sutherland; S Bao; A J Husband
Journal:  Immunol Cell Biol       Date:  1995-10       Impact factor: 5.126

7.  IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis.

Authors:  K F Hoffmann; A W Cheever; T A Wynn
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

8.  Influence of murine hepatitis induced by D-(+)-galactosamine hydrochloride and lipopolysaccharide on gene expression of polyethylenimine/plasmid DNA polyplex.

Authors:  Kei Miyanaga; Takashi Yoshioka; Hiroo Nakagawa; Takashi Kitahara; Hideto To; Nobuhiro Ichikawa; Mikiro Nakashima; Koyo Nishida; Junzo Nakamura; Hitoshi Sasaki
Journal:  Biol Pharm Bull       Date:  2008-08       Impact factor: 2.233

9.  Liver transplantation for acute hepatic failure.

Authors:  Eric T Castaldo; Ravi S Chari
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 10.  Selective IgA deficiency.

Authors:  Leman Yel
Journal:  J Clin Immunol       Date:  2010-01-26       Impact factor: 8.317

View more
  3 in total

1.  Expression and distribution of immunoglobulin G in the normal liver, hepatocarcinoma and postpartial hepatectomy liver.

Authors:  Yu Lei; Tao Huang; Meng Su; Jin Luo; Christine Korteweg; Jing Li; Zhengshan Chen; Yamei Qiu; Xingmu Liu; Meiling Yan; Yun Wang; Jiang Gu
Journal:  Lab Invest       Date:  2014-09-29       Impact factor: 5.662

2.  Effect of nitric oxide pathway regulation on water/sodium balance and renal function in a rodent model of acute liver and renal failure.

Authors:  Marek Saracyn; Tomasz Ząbkowski; Robert Zdanowski; Marek Brytan; Janusz Patera; Zbigniew Nowak; Grzegorz Kade; Zofia Wańkowicz
Journal:  Med Sci Monit       Date:  2014-09-27

3.  Strain of experimental animals and modulation of nitric oxide pathway: their influence on development of renal failure in an experimental model of hepatorenal syndrome.

Authors:  Marek Saracyn; Janusz Patera; Janusz Kocik; Marek Brytan; Robert Zdanowski; Arkadiusz Lubas; Wojciech Kozłowski; Zofia Wańkowicz
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.